Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients

Jun Tang; Rong Deng; Rong-Zhen Luo; Guo-Ping Shen; Mu-Yan Cai; Zi-Ming Du; Shan Jiang; Ming-Tian Yang; Jian-Hua Fu; Xiao-Feng Zhu

doi:10.1007/s10549-016-3703-5

Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients

Breast Cancer Res Treat. 2016 Apr;156(2):403-4. doi: 10.1007/s10549-016-3703-5.

Authors

Jun Tang^{1

2}, Rong Deng¹, Rong-Zhen Luo^{1

3}, Guo-Ping Shen¹, Mu-Yan Cai^{1

3}, Zi-Ming Du^{1

3}, Shan Jiang¹, Ming-Tian Yang^{1

2}, Jian-Hua Fu^{4

5}, Xiao-Feng Zhu⁶

Affiliations

¹ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
² Department of Breast Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, China.
³ Department of Pathology, Cancer Center, Sun Yat-sen University, Guangzhou, China.
⁴ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China. fujh@sysucc.org.cn.
⁵ Department of Thoracic Surgery, Cancer Center, Sun Yat-sen University, Guangzhou, China. fujh@sysucc.org.cn.
⁶ State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China. zhuxfeng@mail.sysu.edu.cn.

PMID: 26960710
DOI: 10.1007/s10549-016-3703-5

Abstract

Erratum to: Breast Cancer Res Treat (2012),134:549–560,DOI 10.1007/s10549-012-2080-y. In the original publication of the article, Fig. 5c was published incorrectly. The authors apologize for this error and the correct Fig. 5c is given below.

Publication types

Published Erratum